Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function
Clinical trial NCT02170571 · COMPLETED
Trial details
- NCT number
- NCT02170571
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2005-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.